Worldwide, cancer chemotherapy is linked to persistent severe peripheral nerve pain (neuropathy) for around 4 in every 10 patients treated with these...
Vous n'êtes pas connecté
TUESDAY, Feb. 4, 2025 -- The pooled prevalence of chronic painful neuropathy is 41.22 percent among individuals with chemotherapy-induced peripheral neuropathy (CIPN), according to a meta-analysis published online Jan. 28 in Regional Anesthesia...
Worldwide, cancer chemotherapy is linked to persistent severe peripheral nerve pain (neuropathy) for around 4 in every 10 patients treated with these...
WEDNESDAY, Jan. 29, 2025 -- Four in every 10 cancer patients treated with chemotherapy develop severe peripheral nerve pain, a new evidence review...
Around 4 in every 10 cancer patients taking chemotherapy are affected with severe peripheral nerve pain (neuropathy). Neuropathy is a medlinknervous
Explore how chemotherapy causes peripheral neuropathy in 40% of cancer patients. Learn about the risk factors and the need for personalized...
WEDNESDAY, Feb. 5, 2025 -- The prevalence of preterm birth is slightly higher among liveborn offspring of male adolescents and young adults with...
THURSDAY, Jan. 30, 2025 -- More than 45 percent of patients with type 2 diabetes (T2D) have micronutrient deficiencies, with the most prevalent...
Scientists from the United States found that chemotherapy based on taxa and platinum compounds have found neuropathic pain in 40% of cases. He writes...
TUESDAY, Feb. 4, 2025 -- For patients with BRAF V600E-mutant metastatic colorectal cancer (mCRC), encorafenib + cetuximab (EC) plus standard...
THURSDAY, Jan. 23, 2025 -- For patients with resectable esophageal adenocarcinoma, perioperative chemotherapy with fluorouracil, leucovorin,...
THURSDAY, Jan. 30, 2025 -- The absolute risk for thyroid cancer is low among patients receiving glucagon-like peptide-1 receptor agonist (GLP-1 RA)...